|

Albumin paclitaxel+SOX+BEV+ PD-1 monoclonal antibody therapy Clinical Trials

1 actively recruiting trial

Also known as: PSBP

Pipeline

Phase 2: 1

Top Sponsors

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

  • Diffuse Type Carcinoma1
  • Gastric Cancer1
  • Cancer1

Other1 trial

Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.